Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eculizumab in pediatric PNH
NCT00867932Phase 4Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Oct 2009
- Primary completion
- May 2011
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of eculizumab in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Alexion Pharmaceuticals. Started Oct 2009; status: completed.
02
Drugs
eculizumab
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT00867932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00867932.